Skip to main content

Advertisement

SpringerLink
Log in

P16INK4A positivity in benign, premalignant and malignant cervical glandular lesions: a potential diagnostic problem

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

A wide array of immunohistochemical markers have been evaluated with respect to their specificity in staining dysplastic cervical cells in cervical biopsies and cervical cytological smears. However, there is still a significant demand for better biomarkers to identify neoplastic cervical glandular and squamous epithelial cells precisely. The CDKN2A gene, located on chromosome 9p21, encodes the tumour suppressor protein, p16INK4A, which decelerates the cell cycle by inactivating CDK4 and CDK6. The aim of this study was to compare and contrast the expression pattern of p16INK4A in benign and neoplastic glandular lesions and tubo-endometrioid metaplasia. All cases in each category displayed some p16INK4A expression. Adenocarcinoma and in situ cases showed a combination of intense nuclear and cytoplasmic staining. It was observed that all cases of tubo-endometrioid metaplasia showed occasional nuclear positivity and definite cytoplasmic staining. These findings may have important implications for the potential utility of p16INK4A as a biomarker for glandular dysplastic lesions. While p16INK4A has been demonstrated to be an excellent marker of cervical dysplasia in squamous neoplastic lesions of the cervix, it has potential pitfalls in cervical glandular lesions that may limit the utility of this biomarker in resolving the nature of suspicious glandular lesions, particularly in cytopathology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1 A
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Anderson G, Gordon KC (1996) Tissue processing, microtomy and paraffin sections. In: Bancroft JD, Stevens A (eds) Theory and practice of histological techniques, 4th edn. Churchill & Livingstone, New York

  2. Brown LJ, Wells M (1986) Cervical glandular atypia associated with squamous intraepithelial neoplasia: a premalignant lesion? J Clin Pathol 39:22–28

    CAS  PubMed  Google Scholar 

  3. Cameron, RI, Maxwell, P, Jenkins D, McCluggage WG (2002) Immunohistochemical staining with MIB1, bcl2 and p16INK4A assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia. Histopathology 41:313–321

    Article  CAS  PubMed  Google Scholar 

  4. Cina SJ, Richardson MS (1997) Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. Mod Pathol 10:176–180

    CAS  PubMed  Google Scholar 

  5. Ducatman BS, Wang HH (1993) Tubal metaplasia: a cytologic study with comparison to other neoplastic and non-neoplastic conditions of the endocervix. Diagn Cytopathol 9:98–103

    CAS  PubMed  Google Scholar 

  6. Fountain JW, Karayiorgou M, Ernstoff MS, Kirkwood JM, Volck DR, Titus-Ernstoff L, Bouchard B, Vijayasaradhi S, Houghton AN, Lahti J et al (1992) Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci U S A 89:10557

    CAS  PubMed  Google Scholar 

  7. Friedell G, McKay D (1953) Adenocarcinoma in situ of the endocervix. Cancer 6:887–897

    CAS  PubMed  Google Scholar 

  8. Goldstein NS, Ahmad E (1998) Endocervical glandular atypia: does a preneoplastic lesion of adenocarcinoma in situ exist? Am J Clin Pathol 110:200–209

    CAS  PubMed  Google Scholar 

  9. Havrilesky LJ, Alvarez AA, Whitaker RS, Marks JR, Berchuck A (2001) Loss of expression of the p16 tumour suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations. Gynecol Oncol 83:491–500

    Article  CAS  PubMed  Google Scholar 

  10. Healy E, Rehman I, Angus B, Rees JL (1995) Loss of heterozygosity in sporadic primary cutaneous melanoma. Genes Chromosomes Cancer 12:152

    CAS  PubMed  Google Scholar 

  11. Hopkins MP, Morley GW (1991) A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 77:912–917

    CAS  PubMed  Google Scholar 

  12. Johnson JE, Rahemtulla A (1999) Endocervical glandular neoplasia and its mimics in ThinPrep Pap tests. A descriptive study. Acta Cytol 43:369–375

    CAS  PubMed  Google Scholar 

  13. Jonasson JG, Wang HH (1992) Tubal metaplasia of the uterine cervix: a prevalence study in patients with gynaecological pathologic findings. Int J Gynecol Pathol 11: 89–95

    CAS  PubMed  Google Scholar 

  14. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J, McClure M, Aitken JF, Anderson DE, Bergman W, Frants R, Goldgar DE, Green A, MacLennan R, Martin NG, Meyer LJ, Youl P, Zone JJ, Skolnick MH, Cannon-Albright LA. (1994) Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 8:22

    Article  CAS  Google Scholar 

  15. Keating JT, Cviko A, Riethdorf S, Riethdorf L, Quade BJ, Sun D, Duensing S, Sheets EE, Munger K, Crum CP (2001) Ki-67, Cyclin E, and p16 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 25:884–891

    CAS  PubMed  Google Scholar 

  16. Klaes R, Friedrich T (2001) Overexpression of p16 as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92:276–284

    Article  CAS  PubMed  Google Scholar 

  17. Krane JF, Granter SR (2001) Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases. Cancer 93:8–15

    Article  CAS  PubMed  Google Scholar 

  18. Kudoh K, Ichikawa Y, Yoshida S, Hirai M, Kikuchi Y, Nagata I, Miwa M, Uchida K (2002) Inactivation of p16/CDKN2 and p15/MTS2 is associated with prognosis and response to chemotherapy in ovarian cancer. Int J Cancer 99:579–582

    Article  CAS  PubMed  Google Scholar 

  19. Liao SY, Brewer C (1994) Identification of MN antigen as a marker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinoma. Am J Pathol 145:598–609

    CAS  PubMed  Google Scholar 

  20. Marques T, Andrade LA (1997) Endocervical tubal metaplasia: morphological concepts and practical importance. Rev Assoc Med Bras 43:21–24

    CAS  PubMed  Google Scholar 

  21. McCluggage WG (2002) Recent advances in immunohistochemistry in gynaecological pathology. Histopathology 40:309–326

    Article  CAS  PubMed  Google Scholar 

  22. McCluggage WG (2003) Endocervical glandular lesions: controversial aspects and ancillary techniques. J Clin Pathol 56:164–173

    Article  CAS  PubMed  Google Scholar 

  23. McCluggage WG, Maxwell P, McBride HA, Hamilton PW, Bharucha H (1995) Monoclonal antibodies Ki67 and MIB1 in the distinction of tuboendometrial metaplasia from endocervical adenocarcinoma and adenocarcinoma in situ in formalin-fixed material. Int J Gynecol Pathol 14:209–216

    CAS  PubMed  Google Scholar 

  24. Murphy N, Ring M, Killalea AG, Uhlmann V, O’Donovan M, Mulcahy F, McGuinness E, Griffin, Martin C, Sheils O, O’Leary JJ (2003) P16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 56:56–63

    Article  CAS  PubMed  Google Scholar 

  25. Negri G, Egarter-Vigl E, Kasal A, Roman F, Haitel A, Mian C (2003) p16INK4A is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors. Am J Surg Pathol 27:187–193

    Article  PubMed  Google Scholar 

  26. Nielsen GP, Stemmer-Rachaminov AO (1999) Immunohistochemical survey of p16 expression in normal human adult and infant tissues. Lab Invest 79:1137–1141

    CAS  PubMed  Google Scholar 

  27. Novotny DB, Maygarden S (1992) Tubal metaplasia—a frequent potential pitfall in the cytologic diagnosis of endocervical glandular dysplasia on cervical smears. Acta Cytol 36:1–10

    CAS  PubMed  Google Scholar 

  28. Olivia E, Clement PB (1995) Tubal and tubo-endometrioid metaplasia of the uterine cervix. Unemphasized features that may cause problems in differential diagnosis: a report of 25 cases. Am J Clin Pathol 103:618–623

    PubMed  Google Scholar 

  29. Pacey F, Ayer B, Greenberg M (1988) The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions. III. Pitfalls in diagnosis. Acta Cytol 32:325–330

    CAS  PubMed  Google Scholar 

  30. Riethdorf L, O’Connell JT (2000) Differential expression of MUC2 and MUC5AC in benign and malignant glandular lesions of the cervix uteri. Virchows Arch 437:365–371

    Article  CAS  PubMed  Google Scholar 

  31. Riethdorf L, Riethdorf S (2002) Human papillomaviruses, expression of p16 and early endocervical glandular neoplasia. Hum Pathol 33:899–904

    Article  CAS  PubMed  Google Scholar 

  32. Saegusa M, Machida BD, Okayasu I (2001) Possible associations among expression of p14 (ARF), p16 (INK4A), p21 (WAF1/CIP1), p27 (KIP1) and p53 accumulation and the balance of apoptosis and cell proliferation in ovarian carcinomas. Cancer 92:1177–1189

    Article  CAS  PubMed  Google Scholar 

  33. Saigo PE, Wolinska WH (1985) The role of cytology in the diagnosis and follow up of patients with cervical adenocarcinoma. Acta Cytol 29:785–794

    CAS  PubMed  Google Scholar 

  34. Sano T, Oyama T (1998) Expression status of p16 protein is associated with human papilloma virus oncogenic potential in cervical and genital lesions. Am J Pathol 153:1741–1748

    CAS  PubMed  Google Scholar 

  35. Schwartz S, Weiss N (1986) Increased incidence of adenocarcinoma of the cervix in young women in the United States. Am J Epidemiol 124:1045–1047

    CAS  PubMed  Google Scholar 

  36. Segal GH, Hart WR (1990) Cystic endocervical tunnel clusters: a clinicopathologic study of 29 cases of so-called adenomatous hyperplasia. Am J Surg Pathol 14:895–903

    CAS  PubMed  Google Scholar 

  37. Selvaggi SM, Haefner HK (1997) Microglandular endocervical hyperplasia and tubal metaplasia: pitfalls in the diagnosis of adenocarcinoma on cervical smears. Diagn Cytopathol 16:168–173

    Article  CAS  PubMed  Google Scholar 

  38. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA (1996) Role of the INK4a locus in tumour suppression and cell mortality Cell 85:27

    Article  CAS  Google Scholar 

  39. Suh KS, Silverberg SG (1990) Tubal metaplasia of the uterine cervix. Int J Gynecol Pathol 9:122–128

    CAS  PubMed  Google Scholar 

  40. Umezaki K, Sanezumi M (1998) Immunohistochemical demonstration of aberrant glycosylation and epidermal growth factor receptor in tubal metaplasia of the uterine cervix. Gynecol Oncol 70:40–44

    Article  CAS  PubMed  Google Scholar 

  41. Von Knebel Doeberitz M (2001) New molecular tools for efficient screening of cervical cancer. Dis Markers 17:123–128

    PubMed  Google Scholar 

  42. Williams GH, Romanowski P, Morris L, Madine M, Mills AD, Stoeber K, Marr J, Laskey RA, Coleman N (1998) Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci U S A 95:14932–14937

    Article  CAS  PubMed  Google Scholar 

  43. Wong YF, Chung TK (1999) Methylation of p16 in primary gynaecologic malignancy. Cancer Lett 136:231–235

    Article  CAS  PubMed  Google Scholar 

  44. Yoshinouchi M, Hongo A (2000) Alteration of the CDKN2/P16 gene is not required for HPV-positive uterine cervical cell lines. Int J Oncol 16:537–541

    CAS  PubMed  Google Scholar 

  45. Young RH, Scully RE (1989) Atypical forms of microglandular hyperplasia of the cervix simulating carcinoma: a report of 5 cases and a review of the literature. Am J Surg Pathol 13:50–56

    CAS  Google Scholar 

  46. Zaino RJ (2000) Glandular lesions of the uterine cervix. Mod Pathol 13:261–274

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Health research board, Irish Cancer Society, Royal City of Dublin Hospital Trust.

Author information

Authors and Affiliations

  1. Department of Pathology, Coombe Women’s Hospital, Dublin 8, Ireland

    N. Murphy, C. C. B. B. Heffron, B. King, U. G. Ganuguapati, M. Ring & J. J. O’Leary

  2. Trinity College, Dublin, Ireland

    N. Murphy, M. Ring, E. McGuinness, O. Sheils & J. J. O’Leary

Authors
  1. N. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. C. B. B. Heffron
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. King
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. U. G. Ganuguapati
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Ring
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. McGuinness
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. O. Sheils
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J. J. O’Leary
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. J. O’Leary.

Additional information

N. Murphy and C.C.B.B. Heffron contributed equally to the work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murphy, N., Heffron, C.C.B.B., King, B. et al. P16INK4A positivity in benign, premalignant and malignant cervical glandular lesions: a potential diagnostic problem. Virchows Arch 445, 610–615 (2004). https://doi.org/10.1007/s00428-004-1111-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-004-1111-4

Keywords

Search

Navigation